• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PET finds early coronary disease in diabetic patients

Article

PET may be diagnostically more powerful than ultrasound or CT for identifying early coronary artery disease in patients with type 2 diabetes.

PET may be diagnostically more powerful than ultrasound or CT for identifying early coronary artery disease in patients with type 2 diabetes.

Nuclear cardiologist Dr. Thomas Schindler and colleagues at the University of Geneva in Switzerland and the University of California, Los Angeles measured coronary endothelium dysfunction with nitrogen-13 ammonia PET and rest-stress PET.

They found diabetes patients with normal or elevated blood pressure showed significantly stronger signs of vascular disease than did normal controls. They also compared PET with high-resolution vascular ultrasound and multislice CT coronary calcium tests and found PET more sensitive than either sonography or CT. Results were presented at the 2008 SNM meeting.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.